Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Blum

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Cellular Biochemistry|June 7, 2014
Activation of muscle enhancers by MyoD and epigenetic modifiersRoy Blum
Biomolecular Concepts|April 28, 2015
Stepping inside the realm of epigenetic modifiersRoy Blum
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 17, 2005
Tailoring Ras-pathway--inhibitor combinations for cancer therapyRoy Blum, Yoel Kloog
Epigenetics|July 25, 2013
The role of MyoD1 and histone modifications in the activation of muscle enhancersRoy Blum, Brian D Dynlacht
Recent Patents on Anti-Cancer Drug Discovery|February 22, 2008
Inhibitors of chronically active ras: potential for treatment of human malignanciesRoy Blum, Adrienne D Cox, Yoel Kloog
Molecular Cancer Therapeutics|September 21, 2006
Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosisRoy Blum, Jasmine Jacob-Hirsch, Gideon Rechavi, et al.
Molecular Cell|May 17, 2024
G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivationYong Woo Lee, Uri Weissbein, Roy Blum, et al.
Genes & Development|December 20, 2012
Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1Roy Blum, Vasupradha Vethantham, Christopher Bowman, et al.
Cancer Research|February 12, 2005
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell deathRoy Blum, Jasmine Jacob-Hirsch, Ninette Amariglio, et al.
RNA (New York, N.Y.)|August 28, 2025
Synthetically inducing G-quadruplexes in coronavirus genome reduces infectivityYongWoo Lee, Roy Blum, Tyler Mrozowich, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry|June 7, 2014
Activation of muscle enhancers by MyoD and epigenetic modifiersRoy Blum
Biomolecular Concepts|April 28, 2015
Stepping inside the realm of epigenetic modifiersRoy Blum
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 17, 2005
Tailoring Ras-pathway--inhibitor combinations for cancer therapyRoy Blum, Yoel Kloog
Epigenetics|July 25, 2013
The role of MyoD1 and histone modifications in the activation of muscle enhancersRoy Blum, Brian D Dynlacht
Recent Patents on Anti-Cancer Drug Discovery|February 22, 2008
Inhibitors of chronically active ras: potential for treatment of human malignanciesRoy Blum, Adrienne D Cox, Yoel Kloog
Molecular Cancer Therapeutics|September 21, 2006
Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosisRoy Blum, Jasmine Jacob-Hirsch, Gideon Rechavi, et al.
Molecular Cell|May 17, 2024
G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivationYong Woo Lee, Uri Weissbein, Roy Blum, et al.
Genes & Development|December 20, 2012
Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1Roy Blum, Vasupradha Vethantham, Christopher Bowman, et al.
Cancer Research|February 12, 2005
Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell deathRoy Blum, Jasmine Jacob-Hirsch, Ninette Amariglio, et al.
RNA (New York, N.Y.)|August 28, 2025
Synthetically inducing G-quadruplexes in coronavirus genome reduces infectivityYongWoo Lee, Roy Blum, Tyler Mrozowich, et al.
Pageof 3